跳至主要内容
临床试验/NCT05421650
NCT05421650招募中不适用

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr: A Phase III, Randomized Controlled Clinical Trial

CHA University50 个研究点 分布在 5 个国家目标入组 240 人开始时间: 2022年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
240
试验地点
50
主要终点
PFS

研究概览

简要总结

This study is a prospective, multicenter and randomized clinical trial (DEBULK trial) to determine the therapeutic effect of surgical debulking of bulky or multiple lymph nodes before concurrent chemoradiation therapy (CCRT) in cervical cancer stage IIICr.

详细描述

Bulky or multiple lymph nodes metastasis in cervical cancer shows poor prognosis and can also diminish the effect of radiotherapy or concurrent chemoradiation therapy (CCRT). However, it is difficult to increase the dose of radiation and chemotherapy considering their side effects. Therefore, the objective of this study is to determine the therapeutic effect of surgical debulking of bulky or multiple lymph nodes before concurrent chemoradiation therapy (CCRT) compared to CCRT only, in cervical cancer stage IIICr. This study is a phase III, multicenter and randomized clinical trial (DEBULK trial).

  • Concurrent chemoradiation therapy (CCRT)
  • Surgical debulking of bulky or multiple lymph node followed by CCRT

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

PFS

时间窗: 3 years

Progression-free survival

次要结局

  • Treatment-related complications(3 years)
  • OS(3 years)
  • False positive rate & positive predictive value of bulky or multiple LN imaging(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ju-Won Roh

Principal Investigator

CHA University

研究点 (50)

Loading locations...

相似试验